Adi NatuinZS AssociatesThe need of emerging Routes of Administration (RoA) in an increasingly crowded vaccine landscapeRead about why it is imperative to redefine our vaccination strategies and address vaccine inequity.Jul 23Jul 23
Adi NatuinZS AssociatesWinning in the APAC private vaccines marketOverall, understanding the ecosystem of players and their strategic considerations is key to winning in the private vaccine market in APAC.Jun 14Jun 14
Adi NatuinZS AssociatesBreaking barriers: Evolving role of the private sector in vaccine accessibilityExplore the impact of vaccines in public health and the shift towards private market expansion.Mar 15Mar 15
Adi NatuinZS AssociatesBeyond R&D: AI’s potential to transform the vaccine ecosystemBy: Amandeep Singh, Sanket Shelar, Amudha Sharma, Sara Ackermann, Regan O’Marra, Keely Anderson and Adi Natu (ZS Vaccines Center of…Dec 21, 2023Dec 21, 2023
Adi NatuinZS AssociatesCombination vaccines: Probing hurdles and catalysts behind the buzzBy Keely Anderson, Amandeep Singh, Sanket Shelar, Amudha Sharma and Adi NatuOct 12, 2023Oct 12, 2023